Invitrogen™ Human Ret ELISA Kit

Ref.: BL-RE-106278Manufacturer ref.: EH392RBX5
€2,950.00 excl. VAT

Human Ret quantitates human Ret in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Ret.

Accession number
Membre de la famille des cadhérines 12 ; membre de la famille liée aux cadhérines 16 ; CDHF12 ; CDHR16 ; CG1061 ; CG14396 ; produit génétique CG14396 obtenu à partir de la transcription CG14396-RA ; CG14396-PA ; CG14396-PB ; CG14396-PC ; c-Ret ; fusion CU x 1/RET ; Dmel\CG14396 ; Dmel_CG14396 ; DmHD-59 ; DmRet ; dRet ; D-ret ; EC 2.7.10.1 ; fragment de 120 kDa de cadhérine RET ancrée par membrane cellulaire extracellulaire ; HD-59 ; HSCR1 ; hydroxyaryl-protéine kinase ; kinase Ret ; MEN2 ; MEN2A ; MEN2B ; MTC1 ; OTTHUMP00000216967 ; proto-oncogène c-Ret ; récepteur de la tyrosine-protéine kinase proto-oncogène Ret ; PTC ; réorganisé pendant la transfection ; récepteur de tyrosine kinase ; RET ; gène Ret pour la tyrosine des récepteurs ; Ret oncogène ; proto-oncogène ret ; proto-oncogène ret (néoplasie endocrinienne multiple et carcinome médullaire de la thyroïde 1, maladie de Hirschsprung) ; proto-oncogène Ret (néoplasie
Sensitivity of the dosage
0.61 ng/ml
Product type
ELISA
For use with (equipment)
Colorimetric microplate reader
Gene symbol(s)
RET
Brand
Invitrogen

Human Ret quantitates human Ret in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Ret.

Human Ret quantitates human Ret in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Ret.

The RET is a member of the cadherin superfamily, code one of the receptor kinase tyrosins that are molecules of cell surface that transduce signals for cell growth and differentiation. The RET plays a crucial role in the development of the neural ridge, can undergo oncogenic activation in vivo and in vitro by cytogenetic reorganization. The mutations of the RET gene are associated with multiple endocrine neoplasia, IIA type, multiple endocrine neoplasia, IIB type, Hirschsprung disease and thyroid spinal cord carcinoma. Two variants of transcription coding different isoforms were discovered for the RET gene. Other transcription variants were described for the RET gene, but their biological validity was not confirmed.

Sensitivity

Sensitivity of the dosage: 0.61 ng/ml.

Measurement range

Dose range: 0.61 to 150 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: RETURN.

Samples

Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; serum, 50 µl; plasma, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17175169
Specifications
Accession numberMember of the family of the cadherines 12; member of the family related to the cadherines 16; CDHF12; CDHR16; CG1061; CG14396; genetic product CG14396 obtained from CG14396-RA transcription; CG14396-PA; CG14396-PB; CG14396-PC; c-Ret; fusion CU x 1/RET; Dmel\CG14396; Dmel_CG14396; DmHD
Sensitivity of the dosage0.61 ng/ml
Product typeELISA
For use with (equipment)Colorimetric microplate reader
Gene symbol(s)RET
Marker or dyeHRP
Regulatory statusUse exclusively for research
Test time1 h 20 min
Dose range0.61 to 150 ng/ml
ConjugateBiotin
Type of samplePlasma, Serum, Surnatant
Genetic identification (Enter)P07949
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Quantity5 x 96 tests
TargetRET
Physical characteristics
Volume of sampleSupernatant, 50 µl; serum, 50 µl; plasma, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH392RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.